4//SEC Filing
Finucane Anne A. 4
Accession 0000064803-25-000061
CIK 0000064803other
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:41 PM ET
Size
7.3 KB
Accession
0000064803-25-000061
Insider Transaction Report
Form 4
Finucane Anne A.
Director
Transactions
- Award
Deferred Stock Units
2025-11-20$76.04/sh+1,775.381$135,000→ 16,530.062 totalExercise: $0.00→ Common Stock (1,775.381 underlying) - Award
Common Stock
2025-11-20$76.04/sh+591$44,940→ 591 total
Footnotes (3)
- [F1]Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
- [F2]Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
- [F3]Consists of deferred stock units, each to be converted into one share of common stock and issued in the future, as elected by the Reporting Person.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001511491
Filing Metadata
- Form type
- 4
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:41 PM ET
- Size
- 7.3 KB